{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:02:41Z","timestamp":1788368561578,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T00:00:00Z","timestamp":1601856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006484","name":"Vifor Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009736","name":"Freiwillige Akademische Gesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009736","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Global Health"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/s2214-109x(20)30448-4","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T19:40:28Z","timestamp":1606246828000},"page":"e189-e198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial"],"prefix":"10.1016","volume":"9","author":[{"given":"Fiona","family":"Vanobberghen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Lweno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kuemmerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwaba Dennis","family":"Mwebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Asilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatus","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Mswata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Schmidlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy R","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Abdulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Daubenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Meyer-Monard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2214-109X(20)30448-4_bib1","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0140-6736(17)32130-X","article-title":"Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/S2214-109X(20)30448-4_bib2","series-title":"Worldwide prevalence of anaemia 1993\u20132005: WHO global database on anaemia","author":"de Benoist","year":"2008"},{"key":"10.1016\/S2214-109X(20)30448-4_bib3","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/S0140-6736(10)62304-5","article-title":"Anaemia in low-income and middle-income countries","volume":"378","author":"Balarajan","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2214-109X(20)30448-4_bib4","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1365-2141.2011.08761.x","article-title":"Severe acquired anaemia in Africa: new concepts","volume":"154","author":"van Hensbroek","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/S2214-109X(20)30448-4_bib5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/jn\/135.2.267","article-title":"Maternal iron deficiency anemia affects postpartum emotions and cognition","volume":"135","author":"Beard","year":"2005","journal-title":"J Nutr"},{"key":"10.1016\/S2214-109X(20)30448-4_bib6","series-title":"Guidelines for the use of iron supplements to prevent and treat iron deficiency anemia","author":"Stoltzfus","year":"1998"},{"key":"10.1016\/S2214-109X(20)30448-4_bib7","series-title":"Poor economics: a radical rethinking of the way to fight global poverty","author":"Banerjee","year":"2011"},{"key":"10.1016\/S2214-109X(20)30448-4_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117383","article-title":"Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis","volume":"10","author":"Tolkien","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/S2214-109X(20)30448-4_bib9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2326-11-4","article-title":"Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial data","volume":"11","author":"Moore","year":"2011","journal-title":"BMC Blood Disord"},{"key":"10.1016\/S2214-109X(20)30448-4_bib10","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1111\/j.1537-2995.2009.02327.x","article-title":"Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial","volume":"49","author":"Van Wyck","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/S2214-109X(20)30448-4_bib11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.AOG.0000275286.03283.18","article-title":"Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial","volume":"110","author":"Van Wyck","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S2214-109X(20)30448-4_bib12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s40264-018-0769-5","article-title":"Evaluation of the reported rates of severe hypersensitivity reactions associated with ferric carboxymaltose and iron (iii) isomaltoside 1000 in Europe based on data from EudraVigilance and VigiBase\u2122 between 2014 and 2017","volume":"42","author":"Ehlken","year":"2019","journal-title":"Drug Saf"},{"key":"10.1016\/S2214-109X(20)30448-4_bib13","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1001\/jama.2015.15572","article-title":"Comparative risk of anaphylactic reactions associated with intravenous iron products","volume":"314","author":"Wang","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/S2214-109X(20)30448-4_bib14","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/169107","article-title":"Direct comparison of the safety and efficacy of ferric carboxymaltose versus iron dextran in patients with iron deficiency anemia","volume":"2013","author":"Hussain","year":"2013","journal-title":"Anemia"},{"issue":"suppl 1","key":"10.1016\/S2214-109X(20)30448-4_bib15","first-page":"S83","article-title":"The available intravenous iron formulations: history, efficacy, and toxicology","volume":"21","author":"Auerbach","year":"2017","journal-title":"Hemodial Int"},{"key":"10.1016\/S2214-109X(20)30448-4_bib16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-0031-1296198","article-title":"Differences in spontaneously reported hypersensitivity and serious adverse events for intravenous iron preparations: comparison of Europe and North America","volume":"61","author":"Bailie","year":"2011","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/S2214-109X(20)30448-4_bib17","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/ndt\/gfh820","article-title":"Hypersensitivity reactions and deaths associated with intravenous iron preparations","volume":"20","author":"Bailie","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2214-109X(20)30448-4_bib18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0167-5699(82)90073-1","article-title":"Dextran hypersensitivity","volume":"3","author":"Richter","year":"1982","journal-title":"Immunol Today"},{"key":"10.1016\/S2214-109X(20)30448-4_bib19","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1097\/00007632-200012150-00008","article-title":"SF-36 health survey update","volume":"25","author":"Ware","year":"2000","journal-title":"Spine"},{"key":"10.1016\/S2214-109X(20)30448-4_bib20","series-title":"How to score version 2 of the SF-36 health survey","author":"Ware","year":"2000"},{"key":"10.1016\/S2214-109X(20)30448-4_bib21","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jclinepi.2006.12.001","article-title":"Relative risks and confidence intervals were easily computed indirectly from multivariable logistic regression","volume":"60","author":"Localio","year":"2007","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S2214-109X(20)30448-4_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182250","article-title":"Maternal and fetal risk factors for stillbirth in northern Tanzania: a registry-based retrospective cohort study","volume":"12","author":"Chuwa","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/S2214-109X(20)30448-4_bib24","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1182\/blood-2012-09-453522","article-title":"Control of iron deficiency anemia in low- and middle-income countries","volume":"121","author":"Pasricha","year":"2013","journal-title":"Blood"},{"key":"10.1016\/S2214-109X(20)30448-4_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/A:1026431727374","article-title":"Validation of the Kiswahili version of the SF-36 health survey in a representative sample of an urban population in Tanzania","volume":"8","author":"Wyss","year":"1999","journal-title":"Qual Life Res"},{"key":"10.1016\/S2214-109X(20)30448-4_bib26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1023\/A:1026441415079","article-title":"A Kiswahili version of the SF-36 health survey for use in Tanzania: translation and tests of scaling assumptions","volume":"8","author":"Wagner","year":"1999","journal-title":"Qual Life Res"},{"key":"10.1016\/S2214-109X(20)30448-4_bib27","doi-asserted-by":"crossref","first-page":"e606","DOI":"10.1016\/S2352-3026(19)30200-5","article-title":"The global need and availability of blood products: a modelling study","volume":"6","author":"Roberts","year":"2019","journal-title":"Lancet Haematol"},{"key":"10.1016\/S2214-109X(20)30448-4_bib28","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/jvh.13073","article-title":"High prevalence and poor linkage to care of transfusion-transmitted infections among blood donors in Dar-es-Salaam, Tanzania","volume":"26","author":"Mohamed","year":"2019","journal-title":"J Viral Hepat"},{"key":"10.1016\/S2214-109X(20)30448-4_bib29","series-title":"A pooled analysis of serum phosphate measurements and potential hypophosphataemia events in 45 interventional trials with ferric carboxymaltose","author":"Stein","year":"2020"}],"container-title":["The Lancet Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214109X20304484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214109X20304484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:48:51Z","timestamp":1761994131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214109X20304484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2214109X20304484"],"URL":"https:\/\/doi.org\/10.1016\/s2214-109x(20)30448-4","relation":{},"ISSN":["2214-109X"],"issn-type":[{"value":"2214-109X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Global Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2214-109X(20)30448-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}